Identification of biomarkers for periodontal disease using the immunoproteomics approach

PeerJ. 2016 Aug 24:4:e2327. doi: 10.7717/peerj.2327. eCollection 2016.

Abstract

Background: Periodontitis is one of the most common oral diseases associated with the host's immune response against periodontopathogenic infection. Failure to accurately diagnose the stage of periodontitis has limited the ability to predict disease status. Therefore, we aimed to look for reliable diagnostic markers for detection or differentiation of early stage periodontitis using the immunoprotemic approach.

Method: In the present study, patient serum samples from four distinct stages of periodontitis (i.e., mild chronic, moderate chronic, severe chronic, and aggressive) and healthy controls were subjected to two-dimensional gel electrophoresis (2-DE), followed by silver staining. Notably, we consistently identified 14 protein clusters in the sera of patients and normal controls.

Results: Overall, we found that protein levels were comparable between patients and controls, with the exception of the clusters corresponding to A1AT, HP, IGKC and KNG1 (p < 0.05). In addition, the immunogenicity of these proteins was analysed via immunoblotting, which revealed differential profiles for periodontal disease and controls. For this reason, IgM obtained from severe chronic periodontitis (CP) sera could be employed as a suitable autoantibody for the detection of periodontitis.

Discussion: Taken together, the present study suggests that differentially expressed host immune response proteins could be used as potential biomarkers for screening periodontitis. Future studies exploring the diagnostic potential of such factors are warranted.

Keywords: Biomarker; Immunoblotting; Periodontal disease; Proteomics; Serum immunogenic protein; Two-dimensional electrophoresis.

Grants and funding

This study was supported by the University of Malaya (UM)-High Impact Research (HIR)-the Ministry of Education (MoE) Grant UM/C/625/1/HIR/MOE/DENT/9, UM.C/625/1/HIR/MOHE/MED/16/5 and UM/C/625/1/HIR/MOE/DENT/4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.